Global Cancer Gene Therapy Market 2021-2025 The analyst has been monitoring the cancer gene therapy market and it is poised to grow by $ 2.96 bn during 2021-2025 progressing at a CAGR of 20% during the forecast period. Our report on cancer gene therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the side effects of traditional cancer treatments, benefits associated with gene therapy for cancer treatment and the rising prevalence rate of cancer boosting the demand for cancer therapeutics. In addition, the side effects of traditional cancer treatments is anticipated to boost the growth of the market as well.
The cancer gene therapy market analysis includes application segments and geographical landscapes.
The cancer gene therapy market is segmented as below: By Application
• Oncolytic virotherapy
• Gene transfer
• Gene-induced immunotherapy
By Geographical Landscapes
• North America
This study identifies the rising partnerships and collaborations as one of the prime reasons driving the cancer gene therapy market growth during the next few years. Also, favorable government regulations for gene therapy programs and rapid growth potential in developing economies will lead to sizable demand in the market.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on cancer gene therapy market covers the following areas:
• Cancer gene therapy market sizing
• Cancer gene therapy market forecast
• Cancer gene therapy market industry analysis
Our reports have been used by over 10K customers, including:
The market for cell culture is driven by factors such as rising demand for vaccines, artificial organs and biopharmaceuticals, and growing focus on personalized medicine. Immunization is the most valuable and cost-effective intervention that delivers better health as well as social and economic benefits. Annually, around 2 to 3 million...
Biopharmaceuticals Contract Manufacturing Market Report Overview Biopharmaceuticals Contract Manufacturing market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Biopharmaceuticals Contract Manufacturing market types and applications. It is...
The whole slide imaging market was valued at US$ 419.52 million in 2019 and is projected to reach US$ 1,582.12 million by 2027; it is expected to grow at a CAGR of 18.1% during 2020–2027. Technological advancements in whole slide imaging and increase in adoption of digital pathology. However, the high cost involved in the installation and...
Biopharmaceuticals Market Report Overview Biopharmaceuticals market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Biopharmaceuticals market types and applications. It is a focused study on Biopharmaceuticals market space including global...
Recombinant Protein Market Report Overview Recombinant Protein market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Recombinant Protein market types and applications. It is a focused study on Recombinant Protein market space including global...
“Venetoclax - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Diabetic Macular Edema in 7 Major Markets. A detailed picture of the Venetoclax in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the...
“VENETOCLAX - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Follicular lymphoma in 7 Major Markets. A detailed picture of the VENETOCLAX in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the...
400 pages •
By The Business Research Company
• Feb 2021
Major companies in the biologics market include Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Bristol-Myers Squibb; GlaxoSmithKline Plc. and AbbVie. The global biologics market is expected to grow from $253.41 billion in 2020 to $268.51 billion in 2021 at a compound annual growth rate (CAGR) of 6%. The growth is mainly due to the companies...
The global recombinant proteins market is projected to reach USD 1.7billion by 2026 from USD 1.0billion in 2021, at a CAGR of 9.8% during the forecast period. The market growth is primarily driven by factors such as increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industryacademia collaborations,...
‘Paroxysmal nocturnal hemoglobinuria (PNH) – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the historical and forecasted epidemiology of PNH in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Paroxysmal nocturnal hemoglobinuria (PNH): Disease Understanding PNH...
Stem Cell Transplantation
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.